AEGERION PHARMACEUTICALS INC's ticker is and the CUSIP is 00767EAB8. A total of 15 filers reported holding AEGERION PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 4.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $1,711,000 | -26.2% | 2,650,000 | -11.7% | 0.00% | 0.0% |
| Q1 2018 | $2,318,000 | -4.6% | 3,000,000 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $2,430,000 | -24.7% | 3,000,000 | -25.0% | 0.00% | -50.0% |
| Q3 2017 | $3,228,000 | -19.5% | 4,000,000 | -20.0% | 0.00% | -33.3% |
| Q2 2017 | $4,009,000 | +11.4% | 5,000,000 | 0.0% | 0.00% | -25.0% |
| Q4 2016 | $3,600,000 | -17.1% | 5,000,000 | -23.1% | 0.00% | 0.0% |
| Q3 2016 | $4,340,000 | -3.7% | 6,500,000 | -18.8% | 0.00% | -20.0% |
| Q2 2016 | $4,508,000 | -12.4% | 8,000,000 | -20.0% | 0.01% | -16.7% |
| Q1 2016 | $5,147,000 | -32.8% | 10,000,000 | -13.0% | 0.01% | -25.0% |
| Q4 2015 | $7,661,000 | -49.1% | 11,500,000 | -42.5% | 0.01% | -42.9% |
| Q3 2015 | $15,059,000 | – | 20,000,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Context Capital Management, LLC | 1,500,000 | $1,219,000 | 0.82% |
| EdgePoint Investment Group Inc. | 51,642,000 | $41,704,000 | 0.62% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 16,600,000 | $13,359,000 | 0.60% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 43,150,000 | $34,952,000 | 0.52% |
| Tekla Capital Management LLC | 13,000,000 | $10,303,000 | 0.37% |
| UBS OCONNOR LLC | 26,000,000 | $20,669,000,000 | 0.30% |
| Orbimed Advisors | 15,000,000 | $12,151,000 | 0.12% |
| Baker Brothers Advisors | 9,517,000 | $7,576,000 | 0.06% |
| CSS LLC/IL | 653,000 | $517,000 | 0.02% |
| Allianz Asset Management GmbH | 28,680,000 | $23,232,000 | 0.02% |